About the Authors
- Petra Massoner
-
Contributed equally to this work with: Petra Massoner, Karl G. Kugler
* E-mail: Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)
Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria
- Karl G. Kugler
-
Contributed equally to this work with: Petra Massoner, Karl G. Kugler
Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria
- Karin Unterberger
-
Affiliation Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria
- Ruprecht Kuner
-
Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany
- Laurin A. J. Mueller
-
Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria
- Maria Fälth
-
Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany
- Georg Schäfer
-
Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria
- Christof Seifarth
-
Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria
- Simone Ecker
-
Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria
- Irmgard Verdorfer
-
Affiliation Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria
- Armin Graber
-
Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria
- Holger Sültmann
-
Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany
- Helmut Klocker
-
* E-mail: Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)
Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria
Competing Interests
The authors have read the journal’s policy and have the following conflicts: after discussing with Oncotyrol, Center for Personalized Cancer Medicine GmbH, the authors would like to disclose the following: PM, KU and HK conducted this work as employees/associates of Oncotyrol GmbH. The work to this project was co-funded by Oncotyrol GmbH in the context of the Austrian COMET funding program. Oncotyrol GmbH does not plan to file a patent or commercially pursue the results contained in this manuscript. Consequently no competing interest could be identified in the context of the described work. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PM KK AG HS HK. Performed the experiments: PM KK KU RK LM MF GS CS SE IV HK. Analyzed the data: PM KK RK LM MF GS AG HS HK. Contributed reagents/materials/analysis tools: PM KK RK GS AG HS HK. Wrote the paper: PM KK HK.